MENU
+Compare
BNR
Stock ticker: NASDAQ
AS OF
Dec 18, 04:36 PM (EDT)
Price
$7.06
Change
+$0.34 (+5.06%)
Capitalization
74.76M

BNR Burning Rock Biotech Limited Forecast, Technical & Fundamental Analysis

a company, which engages in the investment of medical fields and specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology

BNR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for BNR with price predictions
Dec 17, 2024

BNR in upward trend: 10-day moving average broke above 50-day moving average on November 15, 2024

The 10-day moving average for BNR crossed bullishly above the 50-day moving average on November 15, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

BNR moved above its 50-day moving average on November 11, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BNR advanced for three days, in of 199 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 78 cases where BNR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BNR moved out of overbought territory on December 10, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 13 similar instances where the indicator moved out of overbought territory. In of the 13 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 37 cases where BNR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BNR turned negative on December 16, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BNR broke above its upper Bollinger Band on November 21, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.593) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.913) is also within normal values, averaging (43.338).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BNR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
BNR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BNR is expected to report earnings to fall 30.38% to -110 cents per share on May 28

Burning Rock Biotech Limited BNR Stock Earnings Reports
Q1'24
Est.
$-1.10
Q4'23
Missed
by $0.29
Q3'23
Missed
by $0.39
Q2'23
Beat
by $0.09
Q1'23
Beat
by $0.13
The last earnings report on March 28 showed earnings per share of -158 cents, missing the estimate of -128 cents. With 13.36K shares outstanding, the current market capitalization sits at 74.76M.
A.I. Advisor
published General Information

General Information

a company, which engages in the investment of medical fields and specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
No. 5, Xingdao Ring Road North
Phone
+86 2034037871
Employees
1138
Web
https://www.brbiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPCR31.480.48
+1.55%
Structure Therapeutics
ALLO2.070.01
+0.49%
Allogene Therapeutics
GE165.800.01
+0.01%
GE Aerospace
HOWL1.64-0.02
-1.20%
Werewolf Therapeutics
AAON128.67-5.99
-4.45%
AAON

BNR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BNR has been loosely correlated with SINT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BNR jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNR
1D Price
Change %
BNR100%
+0.30%
SINT - BNR
39%
Loosely correlated
+1.32%
NARI - BNR
30%
Poorly correlated
-1.04%
ZOM - BNR
28%
Poorly correlated
+0.91%
ZIMV - BNR
28%
Poorly correlated
+1.60%
RVTY - BNR
25%
Poorly correlated
-0.36%
More